Login to Your Account


Approvals on the Rise, Though Translational Work Still Key

By Nuala Moran
Staff Writer

Tuesday, February 19, 2013
BOSTON – The rise in the number of new drug approvals granted by the FDA in the past three years looks encouraging – hinting as it does that the industry is putting the productivity woes of the previous decade behind it.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription